Prion protein and aging

Frontiers in Cell and Developmental Biology

Volumn 2, Issue AUG, 2014, Pages

  Gasperini, Lisa ^a   Legname, Giuseppe ^a  

^a SISSA   (Italy)

Author keywords

Aging; Alzheimer disease; Prion diseases; PrP

Indexed keywords

EID: 85020658863     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2014.00044     Document Type: Review

References (108)

1. Agostini, F., Dotti, C. G., Perez-Canamas, A., Ledesma, M. D., Benetti, F., and Legname, G. (2013). Prion protein accumulation in lipid rafts of mouse aging brain. PLoS ONE 8:e74244. doi: 10.1371/journal.pone.0074244
2. Aguzzi, A., Baumann, F., and Bremer, J. (2008). The prion's elusive reason for being. Annu. Rev. Neurosci. 31, 439-477. doi: 10.1146/annurev.neuro.31.060407.125620
3. Arena, G., La Mendola, D., Pappalard, G., Sóvágód, I., and Rizzarelli, E. (2012). Interactions of Cu2+ with prion family peptide fragments: considerations on affinity, speciation and coordination. Coord. Chem. Rev. 256, 2202-2218. doi: 10.1016/j.ccr.2012.03.038
4. Avery, S. V. (2001). Metal toxicity in yeasts and the role of oxidative stress. Adv. Appl. Microbiol. 49, 111-142. doi: 10.1016/S0065-2164(01)49011-3
5. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., et al. (2010). Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U.S.A. 107, 2295-2300. doi: 10.1073/pnas.0911829107
6. Bartzokis, G. (2011). Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32, 1341-1371. doi: 10.1016/j.neurobiolaging.2009.08.007
7. Bendlin, B. B., Carlsson, C. M., Gleason, C. E., Johnson, S. C., Sodhi, A., Gallagher, C. L., et al. (2010). Midlife predictors of Alzheimer's disease. Maturitas 65, 131-137. doi: 10.1016/j.maturitas.2009.12.014
8. Benetti, F., Ventura, M., Salmini, B., Ceola, S., Carbonera, D., Mammi, S., et al. (2010). Cuprizone neurotoxicity, copper deficiency and neurodegeneration. Neurotoxicology 31, 509-517. doi: 10.1016/j.neuro.2010.05.008
9. Benvegnu, S., Gasperini, L., and Legname, G. (2011). Aged PrP null mice show defective processing of neuregulins in the peripheral nervous system. Mol. Cell. Neurosci. 47, 28-35. doi: 10.1016/j.mcn.2011.02.005
10. Benvegnu, S., Poggiolini, I., and Legname, G. (2010). Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse. J. Comp. Neurol. 518, 1879-1891. doi: 10.1002/cne.22357
11. Bounhar, Y., Mann, K. K., Roucou, X., and LeBlanc, A. C. (2006). Prion protein prevents Bax-mediated cell death in the absence of other Bcl-2 family members in Saccharomyces cerevisiae. FEMS Yeast Res. 6, 1204-1212. doi: 10.1111/j.1567-1364.2006.00122.x
12. Bowen, R. L., and Atwood, C. S. (2004). Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology 50, 265-290. doi: 10.1159/000079125
13. Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., et al. (2010). Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci. 13, 310-318. doi: 10.1038/nn.2483
14. Brody, H. (1955). Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex. J. Comp. Neurol. 102, 511-516. doi: 10.1002/cne.901020206
15. Brown, D. R., and Besinger, A. (1998). Prion protein expression and superoxide dismutase activity. Biochem. J. 334(Pt 2), 423-429
16. Brown, D. R., Clive, C., and Haswell, S. J. (2001). Antioxidant activity related to copper binding of native prion protein. J. Neurochem. 76, 69-76. doi: 10.1046/j.1471-4159.2001.00009.x
17. Brown, D. R., and Sassoon, J. (2002). Copper-dependent functions for the prion protein. Mol. Biotechnol. 22, 165-178. doi: 10.1385/MB:22:2:165
18. Brown, D. R., Schulz-Schaeffer, W. J., Schmidt, B., and Kretzschmar, H. A. (1997). Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146, 104-112. doi: 10.1006/exnr.1997.6505
19. Brown, D. R., Wong, B. S., Hafiz, F., Clive, C., Haswell, S. J., and Jones, I. M. (1999). Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344(Pt 1), 1-5. doi: 10.1042/0264-6021:3440001
20. Brown, L. R., and Harris, D. A. (2003). Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi. J. Neurochem. 87, 353-363. doi: 10.1046/j.1471-4159.2003.01996.x
21. Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., DeArmond, S. J., et al. (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582. doi: 10.1038/356577a0
22. Burke, S. N., and Barnes, C. A. (2006). Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7, 30-40. doi: 10.1038/nrn1809
23. Burns, A., and Iliffe, S. (2009). Alzheimer's disease. BMJ 338, b158. doi: 10.1136/bmj.b158
24. Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., et al. (2010). Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314. doi: 10.1002/emmm.201000082
25. Chattopadhyay, M., Walter, E. D., Newell, D. J., Jackson, P. J., Aronoff-Spencer, E., Peisach, J., et al. (2005). The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4. J. Am. Chem. Soc. 127, 12647-12656. doi: 10.1021/ja053254z
26. Chung, E., Ji, Y., Sun, Y., Kascsak, R. J., Kascsak, R. B., Mehta, P. D., et al. (2010). Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci. 11:130. doi: 10.1186/1471-2202-11-130
27. Coitinho, A. S., Roesler, R., Martins, V. R., Brentani, R. R., and Izquierdo, I. (2003). Cellular prion protein ablation impairs behavior as a function of age. Neuroreport 14, 1375-1379. doi: 10.1097/01.wnr.0000078541.07662.90
28. Collinge, J. (2001). Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550. doi: 10.1146/annurev.neuro.24.1.519
29. Cowan, C. M., Thai, J., Krajewski, S., Reed, J. C., Nicholson, D. W., Kaufmann, S. H., et al. (2001). Caspases 3 and 9 send a pro-apoptotic signal from synapse to cell body in olfactory receptor neurons. J. Neurosci. 21, 7099-7109
30. Cui, T., Daniels, M., Wong, B. S., Li, R., Sy, M. S., Sassoon, J., et al. (2003). Mapping the functional domain of the prion protein. Eur. J. Biochem. 270, 3368-3376. doi: 10.1046/j.1432-1033.2003.03717.x
31. DeArmond, S. J., Mobley, W. C., DeMott, D. L., Barry, R. A., Beckstead, J. H., and Prusiner, S. B. (1987). Changes in the localization of brain prion proteins during scrapie infection. Neurology 37, 1271-1280. doi: 10.1212/WNL.37.8.1271
32. Dohler, F., Sepulveda-Falla, D., Krasemann, S., Altmeppen, H., Schluter, H., Hildebrand, D., et al. (2014). High molecular mass assemblies of amyloid-beta oligomers bind prion protein in patients with Alzheimer's disease. Brain 137(Pt 3), 873-886. doi: 10.1093/brain/awt375
33. Dong, C. F., Shi, S., Wang, X. F., An, R., Li, P., Chen, J. M., et al. (2008). The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Arch. Biochem. Biophys. 470, 83-92. doi: 10.1016/j.abb.2007.11.007
34. Esiri, M. M. (2007). Ageing and the brain. J. Pathol. 211, 181-187. doi: 10.1002/path.2089
35. Flurkey, K., Currer, J. M., and Harrison, D. E. (2007). 'The mouse in aging research'. in The Mouse in Biomedical Research, Vol. 3, ed J. G. Fox (Burlington, MA: Elsevier), 637-672
36. Fournier, J. G., Escaig-Haye, F., Billette de Villemeur, T., Robain, O., Lasmezas, C. I., Deslys, J. P., et al. (1998). Distribution and submicroscopic immunogold localization of cellular prion protein (PrPc) in extracerebral tissues. Cell Tissue Res. 292, 77-84. doi: 10.1007/s004410051036
37. Goh, A. X., Li, C., Sy, M. S., and Wong, B. S. (2007). Altered prion protein glycosylation in the aging mouse brain. J. Neurochem. 100, 841-854. doi: 10.1111/j.1471-4159.2006.04268.x
38. Goldmann, W., O'Neill, G., Cheung, F., Charleson, F., Ford, P., and Hunter, N. (1999). PrP (prion) gene expression in sheep may be modulated by alternative polyadenylation of its messenger RNA. J. Gen. Virol. 80(Pt 8), 2275-2283
39. Halliwell, B. (2006). Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97, 1634-1658. doi: 10.1111/j.1471-4159.2006.03907.x
40. Haraguchi, T., Fisher, S., Olofsson, S., Endo, T., Groth, D., Tarentino, A., et al. (1989). Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch. Biochem. Biophys. 274, 1-13. doi: 10.1016/0003-9861(89)90409-8
41. Hedden, T., and Gabrieli, J. D. (2004). Insights into the ageing mind: a view from cognitive neuroscience. Nat. Rev. Neurosci. 5, 87-96. doi: 10.1038/nrn1323
42. Horiuchi, M., Yamazaki, N., Ikeda, T., Ishiguro, N., and Shinagawa, M. (1995). A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J. Gen. Virol. 76(Pt 10), 2583-2587. doi: 10.1099/0022-1317-76-10-2583
43. Hornshaw, M. P., McDermott, J. R., and Candy, J. M. (1995). Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207, 621-629. doi: 10.1006/bbrc.1995.1233
44. Jackson, G. S., Murray, I., Hosszu, L. L., Gibbs, N., Waltho, J. P., Clarke, A. R., et al. (2001). Location and properties of metal-binding sites on the human prion protein. Proc. Natl. Acad. Sci. U.S.A. 98, 8531-8535. doi: 10.1073/pnas.151038498
45. Kellett, K. A., and Hooper, N. M. (2009). Prion protein and Alzheimer disease. Prion 3, 190-194. doi: 10.4161/pri.3.4.9980
46. Kessels, H. W., Nguyen, L. N., Nabavi, S., and Malinow, R. (2010). The prion protein as a receptor for amyloid-beta. Nature 466, E3-E4. discussion: E-5. doi: 10.1038/nature09217
47. Kitamoto, T., Iizuka, R., and Tateishi, J. (1993). An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem. Biophys. Res. Commun. 192, 525-531. doi: 10.1006/bbrc.1993.1447
48. Kralovicova, S., Fontaine, S. N., Alderton, A., Alderman, J., Ragnarsdottir, K. V., Collins, S. J., et al. (2009). The effects of prion protein expression on metal metabolism. Mol. Cell. Neurosci. 41, 135-147. doi: 10.1016/j.mcn.2009.02.002
49. Lasmezas, C. I., Deslys, J. P., Robain, O., Jaegly, A., Beringue, V., Peyrin, J. M., et al. (1997). Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275, 402-405. doi: 10.1126/science.275.5298.402
50. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132. doi: 10.1038/nature07761
51. Lehmann, S., and Harris, D. A. (1997). Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J. Biol. Chem. 272, 21479-21487. doi: 10.1074/jbc.272.34.21479
52. Liu, L., Jiang, D., McDonald, A., Hao, Y., Millhauser, G. L., and Zhou, F. (2011). Copper redox cycling in the prion protein depends critically on binding mode. J. Am. Chem. Soc. 133, 12229-12237. doi: 10.1021/ja2045259
53. Lo, R. Y., Shyu, W. C., Lin, S. Z., Wang, H. J., Chen, S. S., and Li, H. (2007). New molecular insights into cellular survival and stress responses: neuroprotective role of cellular prion protein (PrPC). Mol. Neurobiol. 35, 236-244. doi: 10.1007/s12035-007-8003-y
54. Malaga-Trillo, E., Solis, G. P., Schrock, Y., Geiss, C., Luncz, L., Thomanetz, V., et al. (2009). Regulation of embryonic cell adhesion by the prion protein. PLoS Biol. 7:e55. doi: 10.1371/journal.pbio.1000055
55. Martin, M., Dotti, C. G., and Ledesma, M. D. (2010). Brain cholesterol in normal and pathological aging. Biochim. Biophys. Acta 1801, 934-944. doi: 10.1016/j.bbalip.2010.03.011
56. Martin, M. G., Perga, S., Trovo, L., Rasola, A., Holm, P., Rantamaki, T., et al. (2008). Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol. Biol. Cell 19, 2101-2112. doi: 10.1091/mbc.E07-09-0897
57. Massimino, M. L., Redaelli, M., Bertoli, A., Sorgato, M. C., and Mucignat-Caretta, C. (2013). Altered behavioral aspects of aged mice lacking the cellular prion protein. Physiol. Behav. 119, 86-91. doi: 10.1016/j.physbeh.2013.06.006
58. McLennan, N. F., Brennan, P. M., McNeill, A., Davies, I., Fotheringham, A., Rennison, K. A., et al. (2004). Prion protein accumulation and neuroprotection in hypoxic brain damage. Am. J. Pathol. 165, 227-235. doi: 10.1016/S0002-9440(10)63291-9
59. Meyne, F., Gloeckner, S. F., Ciesielczyk, B., Heinemann, U., Krasnianski, A., Meissner, B., et al. (2009). Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J. Alzheimers. Dis. 17, 863-873. doi: 10.3233/JAD-2009-1110
60. Mitsios, N., Saka, M., Krupinski, J., Pennucci, R., Sanfeliu, C., Miguel Turu, M., et al. (2007). Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J. Neurosci. Res. 85, 602-611. doi: 10.1002/jnr.21142
61. Miura, T., Sasaki, S., Toyama, A., and Takeuchi, H. (2005). Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. Biochemistry 44, 8712-8720. doi: 10.1021/bi0501784
62. Morales, R., Estrada, L. D., Diaz-Espinoza, R., Morales-Scheihing, D., Jara, M. C., Castilla, J., et al. (2010). Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J. Neurosci. 30, 4528-4535. doi: 10.1523/JNEUROSCI.5924-09.2010
63. Moudjou, M., Bernard, J., Sabuncu, E., Langevin, C., and Laude, H. (2007). Glycan chains modulate prion protein binding to immobilized metal ions. Neurochem. Int. 50, 689-695. doi: 10.1016/j.neuint.2007.01.001
64. Moudjou, M., Frobert, Y., Grassi, J., and La Bonnardière, C. (2001). Cellular prion protein status in sheep: tissue-specific biochemical signatures. J. Gen. Virol. 82(Pt 8), 2017-2024. doi: 10.1099/vir.0.17776-0
65. Nazor, K. E., Seward, T., and Telling, G. C. (2007). Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression. Biochim. Biophys. Acta 1772, 645-653. doi: 10.1016/j.bbadis.2007.04.004
66. Ordonez-Gutierrez, L., Torres, J. M., Gavin, R., Anton, M., Arroba-Espinosa, A. I., Espinosa, J. C., et al. (2013). Cellular prion protein modulates beta-amyloid deposition in aged APP/PS1 transgenic mice. Neurobiol. Aging 34, 2793-2804. doi: 10.1016/j.neurobiolaging.2013.05.019
67. Pan, T., Li, R., Kang, S. C., Pastore, M., Wong, B. S., Ironside, J., et al. (2005a). Biochemical fingerprints of prion diseases: scrapie prion protein in human prion diseases that share prion genotype and type. J. Neurochem. 92, 132-142. doi: 10.1111/j.1471-4159.2004.02859.x
68. Pan, T., Li, R., Wong, B. S., Kang, S. C., Ironside, J., and Sy, M. S. (2005b). Novel antibody-lectin enzyme-linked immunosorbent assay that distinguishes prion proteins in sporadic and variant cases of Creutzfeldt-Jakob disease. J. Clin. Microbiol. 43, 1118-1126. doi: 10.1128/JCM.43.3.1118-1126.2005
69. Pan, T., Li, R., Wong, B. S., Liu, T., Gambetti, P., and Sy, M. S. (2002). Heterogeneity of normal prion protein in two-dimensional immunoblot: presence of various glycosylated and truncated forms. J. Neurochem. 81, 1092-1101. doi: 10.1046/j.1471-4159.2002.00909.x
70. Pan, T., Wong, P., Chang, B., Li, C., Li, R., Kang, S. C., et al. (2005c). Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J. Virol. 79, 934-943. doi: 10.1128/JVI.79.2.934-943.2005
71. Parkin, E. T., Watt, N. T., Hussain, I., Eckman, E. A., Eckman, C. B., Manson, J. C., et al. (2007). Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 104, 11062-11067. doi: 10.1073/pnas.0609621104
72. Pauly, P. C., and Harris, D. A. (1998). Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110. doi: 10.1074/jbc.273.50.33107
73. Peralta, O. A., Huckle, W. R., and Eyestone, W. H. (2012). Developmental expression of the cellular prion protein (PrP(C)) in bovine embryos. Mol. Reprod. Dev. 79, 488-498. doi: 10.1002/mrd.22057
74. Peters, A. (2002). The effects of normal aging on myelin and nerve fibers: a review. J. Neurocytol. 31, 581-593. doi: 10.1023/A:1025731309829
75. Prusiner, S. B. (1991). Molecular biology and transgenetics of prion diseases. Crit. Rev. Biochem. Mol. Biol. 26, 397-438. doi: 10.3109/10409239109086789
76. Prusiner, S. B. (1994). Biology and genetics of prion diseases. Annu. Rev. Microbiol. 48, 655-686. doi: 10.1146/annurev.mi.48.100194.003255
77. Prusiner, S. B. (2001). Shattuck lecture-neurodegenerative diseases and prions. N. Engl. J. Med. 344, 1516-1526. doi: 10.1056/NEJM200105173442006
78. Querfurth, H. W., and LaFerla, F. M. (2010). Alzheimer's disease. N. Engl. J. Med. 362, 329-344. doi: 10.1056/NEJMra0909142
79. Rachidi, W., Vilette, D., Guiraud, P., Arlotto, M., Riondel, J., Laude, H., et al. (2003). Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278, 9064-9072. doi: 10.1074/jbc.M211830200
80. Rial, D., Duarte, F. S., Xikota, J. C., Schmitz, A. E., Dafre, A. L., Figueiredo, C. P., et al. (2009). Cellular prion protein modulates age-related behavioral and neurochemical alterations in mice. Neuroscience 164, 896-907. doi: 10.1016/j.neuroscience.2009.09.005
81. Roucou, X., and LeBlanc, A. C. (2005). Cellular prion protein neuroprotective function: implications in prion diseases. J. Mol. Med. (Berl.) 83, 3-11. doi: 10.1007/s00109-004-0605-5
82. Safar, J., Wang, W., Padgett, M. P., Ceroni, M., Piccardo, P., Zopf, D., et al. (1990). Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer. Proc. Natl. Acad. Sci. U.S.A. 87, 6373-6377. doi: 10.1073/pnas.87.16.6373
83. Saijo, E., Scheff, S. W., and Telling, G. C. (2011). Unaltered prion protein expression in Alzheimer disease patients. Prion 5, 109-116. doi: 10.4161/pri.5.2.16355
84. Sales, N., Hassig, R., Rodolfo, K., Di Giamberardino, L., Traiffort, E., Ruat, M., et al. (2002). Developmental expression of the cellular prion protein in elongating axons. Eur. J. Neurosci. 15, 1163-1177. doi: 10.1046/j.1460-9568.2002.01953.x
85. Scheibel, A. B. (1979). Dendritic changes in senile and presenile dementias. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 57, 107-124
86. Scheibel, M. E., Lindsay, R. D., Tomiyasu, U., and Scheibel, A. B. (1976). Progressive dendritic changes in the aging human limbic system. Exp. Neurol. 53, 420-430. doi: 10.1016/0014-4886(76)90082-0
87. Schmitz, M., Greis, C., Ottis, P., Silva, C. J., Schulz-Schaeffer, W. J., Wrede, A., et al. (2014). Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression. Mol. Neurobiol. doi: 10.1007/s12035-014-8655-3. [Epub ahead of print]
88. Schwarze-Eicker, K., Keyvani, K., Gortz, N., Westaway, D., Sachser, N., and Paulus, W. (2005). Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiol. Aging 26, 1177-1182. doi: 10.1016/j.neurobiolaging.2004.10.004
89. Shyu, W. C., Chen, C. P., Saeki, K., Kubosaki, A., Matusmoto, Y., Onodera, T., et al. (2005). Hypoglycemia enhances the expression of prion protein and heat-shock protein 70 in a mouse neuroblastoma cell line. J. Neurosci. Res. 80, 887-894. doi: 10.1002/jnr.20509
90. Shyu, W. C., Kao, M. C., Chou, W. Y., Hsu, Y. D., and Soong, B. W. (2000). Heat shock modulates prion protein expression in human NT-2 cells. Neuroreport 11, 771-774. doi: 10.1097/00001756-200003200-00023
91. Shyu, W. C., Lin, S. Z., Saeki, K., Kubosaki, A., Matsumoto, Y., Onodera, T., et al. (2004). Hyperbaric oxygen enhances the expression of prion protein and heat shock protein 70 in a mouse neuroblastoma cell line. Cell. Mol. Neurobiol. 24, 257-268. doi: 10.1023/B:CEMN.0000018620.41913.d2
92. Singh, A., Kong, Q., Luo, X., Petersen, R. B., Meyerson, H., and Singh, N. (2009). Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport. PLoS ONE 4:e6115. doi: 10.1371/journal.pone.0006115
93. Singh, N., Das, D., Singh, A., and Mohan, M. L. (2010). Prion protein and metal interaction: physiological and pathological implications. Curr. Issues Mol. Biol. 12, 99-107
94. Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., et al. (2008). Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 172, 1053-1061. doi: 10.2353/ajpath.2008.070850
95. Stahl, N., Baldwin, M. A., Burlingame, A. L., and Prusiner, S. B. (1990). Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29, 8879-8884. doi: 10.1021/bi00490a001
96. Stockel, J., Safar, J., Wallace, A. C., Cohen, F. E., and Prusiner, S. B. (1998). Prion protein selectively binds copper(II) ions. Biochemistry 37, 7185-7193. doi: 10.1021/bi972827k
97. Thibault, O., Hadley, R., and Landfield, P. W. (2001). Elevated postsynaptic [Ca2+]i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J. Neurosci. 21, 9744-9756
98. Treiber, C., Pipkorn, R., Weise, C., Holland, G., and Multhaup, G. (2007). Copper is required for prion protein-associated superoxide dismutase-I activity in Pichia pastoris. FEBS J. 274, 1304-1311. doi: 10.1111/j.1742-4658.2007.05678.x
99. Trovo, L., Van Veldhoven, P. P., Martin, M. G., and Dotti, C. G. (2011). Sphingomyelin upregulation in mature neurons contributes to TrkB activity by Rac1 endocytosis. J. Cell Sci. 124(Pt 8), 1308-1315. doi: 10.1242/jcs.078766
100. Vassallo, N., and Herms, J. (2003). Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J. Neurochem. 86, 538-544. doi: 10.1046/j.1471-4159.2003.01882.x
101. Verdu, E., Ceballos, D., Vilches, J. J., and Navarro, X. (2000). Influence of aging on peripheral nerve function and regeneration. J. Peripher. Nerv. Syst. 5, 191-208. doi: 10.1046/j.1529-8027.2000.00026.x
102. Watt, N. T., Taylor, D. R., Gillott, A., Thomas, D. A., Perera, W. S., and Hooper, N. M. (2005). Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem. 280, 35914-35921. doi: 10.1074/jbc.M507327200
103. Whitehouse, I. J., Jackson, C., Turner, A. J., and Hooper, N. M. (2010). Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease. J. Alzheimers. Dis. 22, 1023-1031. doi: 10.3233/JAD-2010-101071
104. Williams, W. M., Stadtman, E. R., and Moskovitz, J. (2004). Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma. Neuropathol. Appl. Neurobiol. 30, 161-168. doi: 10.1111/j.1365-2990.2003.00523.x
105. Wong, B. S., Liu, T., Li, R., Pan, T., Petersen, R. B., Smith, M. A., et al. (2001). Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem. 76, 565-572. doi: 10.1046/j.1471-4159.2001.00028.x
106. Yoshioka, Y., Ishiguro, N., and Inoshima, Y. (2010). Proteasome activity and biological properties of normal prion protein: a comparison between young and aged cattle. J. Vet. Med. Sci. 72, 1583-1587. doi: 10.1292/jvms.10-0149
107. Zahn, R., Liu, A., Luhrs, T., Riek, R., von Schroetter, C., Lopez Garcia, F., et al. (2000). NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. U.S.A. 97, 145-150. doi: 10.1073/pnas.97.1.145
108. Zhu, X., Su, B., Wang, X., Smith, M. A., and Perry, G. (2007). Causes of oxidative stress in Alzheimer disease. Cell. Mol. Life Sci. 64, 2202-2210. doi: 10.1007/s00018-007-7218-4